Strata Critical Medical, Inc., trading under the ticker BLDE, filed an 8-K current report with the SEC on June 3, 2026, bearing accession number 0001628280-26-040342. The company operates in the critical and acute-care medical sector, reflecting the continued SPAC market's interest in healthcare services and medtech targets that emerged prominently in the early-to-mid 2020s wave of blank-check activity. The 8-K filing signals a material corporate event requiring timely public disclosure under Exchange Act reporting obligations. Full sponsor details, deal history, and filing analytics for Strata Critical Medical are available on SpacDesk — sign up at SpacDesk.com to access comprehensive SPAC data, filings, and real-time monitoring across the full universe of blank-check transactions.